Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human DIO2 ELISA Kit (AC3419)
Cat.#: ASET-2008
Specifications
Description Human DIO2 ELISA Kit is a competitive Enzyme-Linked Immunosorbent Assay (cELISA) designed for the in vitro quantitative determination of human DIO2 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1561 Rat HDL ELISA Kit (AC2972) Quantitative inquiry ASET-2050 Human MAL ELISA Kit (AC3461) Quantitative inquiry ASET-1001 Human Apo-D ELISA Kit (AC2412) Quantitative inquiry ASET-1818 Mouse iNOS ELISA Kit (AC3229) Quantitative inquiry ASET-2348 Rat BDNF ELISA Kit (AC3759) Quantitative inquiry ASET-1683 Human NOX3 ELISA Kit (AC3094) Quantitative inquiry ASET-2109 Rat beta 1 Adrenergic Receptor ELISA Kit (AC3520) Quantitative inquiry ASET-1247 Human GSK3 beta ELISA Kit (AC2658) Quantitative inquiry ASET-1995 Human NRG4 ELISA Kit (AC3406) Quantitative inquiry ASET-2440 Rat Semaphorin 3A ELISA Kit (AC3851) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket